-+ 0.00%
-+ 0.00%
-+ 0.00%

Biotechnology Assets Converts EUR 150,000 of Debt Into Equity

PUBT·11/11/2026 17:43:00
Listen to the news
Biotechnology Assets Converts EUR 150,000 of Debt Into Equity
  • Biotechnology Assets converted 15 convertible bonds with a combined nominal value of EUR 150,000 on November 4, 2026.
  • The conversion for Global Corporate Finance Opportunities 9 resulted in 882,352 new ordinary shares at EUR 0.17 each.
  • Share capital increased by EUR 44,117.60 to EUR 3.85 million, represented by 77,009,874 shares.
  • As of November 11, 2026, 25 convertible bonds remained outstanding under the June 2026 authorization, each with EUR 10,000 nominal value.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biotechnology Assets SA published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.